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Abstract
Objective: To determine if real-time compression feedback using a non-automated hand-held device improves
patient outcomes from in-hospital cardiac arrest (IHCA).
Methods: We conducted a prospective, randomized, controlled, parallel study (no crossover) of patients with IHCA in
the mixed medical–surgical intensive care units (ICUs) of eight academic hospitals. Patients received either standard
manual chest compressions or compressions performed with real-time feedback using the Cardio First Angel™ (CFA)
device. The primary outcome was sustained return of spontaneous circulation (ROSC), and secondary outcomes were
survival to ICU and hospital discharge.
Results: One thousand four hundred fifty-four subjects were randomized; 900 were included. Sustained ROSC was
significantly improved in the CFA group (66.7% vs. 42.4%, P < 0.001), as was survival to ICU discharge (59.8% vs. 33.6%)
and survival to hospital discharge (54% vs. 28.4%, P < 0.001). Outcomes were not affected by intra-group comparisons
based on intubation status. ROSC, survival to ICU, and hospital discharge were noted to be improved in inter-group
comparisons of non-intubated patients, but not intubated ones.
Conclusion: Use of the CFA compression feedback device improved event survival and survival to ICU and hospital
discharge.
Trial registration: The study was registered with Clinicaltrials.gov (NCT02845011), registered retrospectively on July 21, 2016.
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Introduction
Effective chest compression remains the cornerstone of
successful cardiopulmonary resuscitation (CPR) [1–7].
International guidelines note the critical importance of
compression components including position, rate, force,
depth, interruptions, recoil, excessive ventilation avoid-
ance, no-flow time, and flow fraction [4–8]. However,
observational data suggest that compressions delivered
in practice may be suboptimal [9]. Strategies that im-
prove guideline adherence may improve cardiac arrest
outcomes. Real-time audiovisual feedback (AVF) and
post-event debriefing have been identified as two such
strategies [4, 10–12].
Several chest compression feedback devices have been
marketed. Those not associated with automated external
defibrillators (non-AED) require active chest compression,
and most utilize passive decompression. The associated
feedback technology ranges in complexity from a simple
metronome to electromagnetic sensing [7, 13–16]. Despite
a paucity of evidence, the American Heart Association
(AHA) and the International Liaison Committee on Re-
suscitation (ILCOR) have both made cautious recommen-
dations supporting AVF device use [4, 6, 17].
To date, nine non-AED active compression-passive de-
compression feedback devices have been tested in simula-
tion and clinical environments [7, 13–16, 18–22]. Only one
study assessing the use of a hand-held AVF device during
in-hospital cardiac arrest (IHCA) has been published [7]. In
a study of patients with IHCA (n = 80), significant improve-
ments in return of spontaneous circulation (ROSC) rates,
guideline adherence, CPR quality, and decreased rib (not
sternum) fracture rates were observed for patients receiving
compressions using the Cardio First Angel™ (CFA) device
[7]. In the current study, we aim to determine if use of the
CFA compression feedback device will improve rates of
sustained ROSC, and survival to intensive care unit (ICU)
and hospital discharge for patients with IHCA.
Methods
Study design and settings
This was a prospective, randomized, controlled, parallel
study of patients undergoing resuscitation with chest com-
pressions for IHCA in the mixed medical-surgical ICUs of
eight academic tertiary care hospitals in Iran from January
1, 2015, to September 15, 2015. All parts of the study were
reviewed according to the Consolidated Standards for
Reporting Trials (CONSORT) statement (Fig. 1) [23]. The
trial was registered with Clinicaltrials.gov (identifier
NCT02845011). The protocol is available for review upon
reasonable request. Crossover was not allowed. Patients
were blinded to randomization group. The healthcare pro-
vider was not blind during the resuscitation, as it was con-
sidered unethical to employ a sham device. The data
analyzer was blinded to group randomization and was not
present during resuscitation.
Block randomization (groups of 4) was performed using a
random number list generated by Random Allocation Soft-
ware© (RAS; Informer Technologies, Inc., Madrid, Spain; Fig.
1). Numbers were placed into sequential containers that were
kept in a secure location until allocation consignment. To
Fig. 1 Flow diagram of patient enrollment
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ensure blinding, the allocation sequence was kept by a differ-
ent investigator than the one enrolling participants. A third in-
vestigator was responsible for patient follow-up and
assessments. Enrollment and randomization occurred in the
emergency department from available admitted ICU patients
on a convenience basis. Only patients admitted to the ICU
through the emergency department were eligible for inclusion.
Patients suffering decompensation in clinical status on the
floor or intermediate care units requiring transfer to the ICU
were not eligible for study inclusion. Patients consented to en-
rollment in a study on cardiac arrest treatment should that
event occur during the ICU stay. A container was kept at the
foot of the bed that either contained the CFA device (interven-
tion) or a weight but no device (control). Upon resuscitation,
the container was opened, and providers proceeded with the
resuscitation accordingly. There were no important changes
to methods after trial commencement. The study ended be-
cause it achieved the necessary sample size.
Patient population
The pre-defined inclusion criteria were as follows: (1) age
≥ 18 years, (2) admitted to the ICU from the emergency
department (ED), (3) resuscitation status (full code), and
(4) informed consent. Patients were excluded from inclu-
sion if pregnant. Subjects excluded from the final analysis
were as follows: (1) any out-of-hospital cardiac arrest or
ED cardiac arrest prior to study enrollment, (2) change in
code status to anything not full code, (3) revoked consent,
or for (4) lost or incomplete data due to logistical impedi-
ment to data collection. Consent decisions were accepted
from either the patient or appropriate legal guardian or
surrogate. Decisions to cease resuscitation efforts were
made by the team leader in accordance with the European
Resuscitation Council and AHA Guidelines for Resuscita-
tion Ethics and included (1) asystole for > 20min in the
absence of a reversible cause [e.g., hypothermia at time of
arrest, cardiac tamponade, tension pneumothorax, dis-
tributive shock from anaphylaxis, and chemical intoxica-
tion/overdose (e.g., opiate)], (2) > 30min of resuscitation
with no occurrence of ventricular fibrillation (VF) or ven-
tricular tachycardia (VT) at any point (initial or subse-
quent rhythm), (3) injury not compatible with life, (4)
severity of comorbidities, and (5) normothermia [24, 25].
For those patients in persistent pulseless VF or VT not re-
sponsive to CPR, defibrillation, and medications, the de-
termination to cease resuscitation efforts was made by the
resuscitation team leader based on the clinical variables
including the following: witnessed versus unwitnessed ar-
rest, time to CPR initiation, comorbid disease, and
pre-arrest state.
Intervention
All arrests were classified as witnessed and monitored as
they occurred in the ICU. Resuscitation teams were
comprised of an intensivist, three to five ICU nurses, and a
respiratory therapist. Resuscitation was in accordance with
standard guidelines, including chest compressions per-
formed by experienced ICU nurses, defibrillation (both au-
tomated and conventional available), indicated medications
(epinephrine, vasopressin, atropine, amiodarone, sodium bi-
carbonate, calcium chloride, magnesium sulfate), and venti-
lation with or without endotracheal intubation [8, 26].
Defibrillation technique for all participants was unchanged
from the standard baseline technique. Prior to study de-
ployment, all ICU nurses at approved study sites received
standardized CPR training in accordance with published
guidelines and training on CFA device use [8, 26]. During
resuscitation, patients in the control group received CPR in
accordance to published guidelines, whereas patients in the
intervention group received compressions with the aid of
the CFA feedback device. Measurement of invasive
hemodynamics was outside the scope of this study.
Cardio First Angel™ device
The Cardio First Angel™ is a handheld device consisting
of three components. The rescuer side has a red
palm-sized push button with a pictogram illustrating
proper use (Fig. 2) [7]. The center unit is composed of a
stable plastic base containing an arrangement of springs,
and the patient side consists of liquid-absorbent polyur-
ethane foam [7]. Application of 400 ± 30 N of force re-
sults in an audible click alerting the rescuer to cease
compression, and an additional click on decompression
alerts the rescuer to resume compression [7].
Data collection
Utstein variables were published after data collection;
however, all available Utstein variables are reported [27].
The primary outcome was sustained ROSC (> 30min).
Secondary outcomes were survival to ICU and hospital
discharge. Recorded data included age, sex, invasive
mechanical ventilation status upon code onset, ICU and
hospital length of stay (LOS), diagnoses, presence of
known osteoporosis, initial cardiac rhythm, defibrilla-
tion, and administered drugs. Trial outcomes were not
changed after trial commencement. Data for invasive ar-
terial monitoring and wave form capnography were not
routinely available for patients and is not reported. The
assessment for multiple-organ dysfunction included (1)
respiratory [ratio of partial pressure arterial oxygen and
fraction of inspired oxygen (PaO2/FiO2), minute ventila-
tion (MV)], (2) hematology [platelets, white blood cells],
(3) liver [bilirubin, prothrombin time], (4) cardiovascular
[mean arterial pressure, systolic blood pressure, heart
rate, vasopressor requirement], (5) CNS [Glasgow coma
score], and (6) renal [creatinine, blood urea nitrogen,
urine output].
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Availability of data and materials
All relevant data are within the paper and its supporting
information files. De-identified individual subject data
may be available from the corresponding author on rea-
sonable request.
Sample size and data analysis
The sample size was based upon the survival and mor-
bidity data reported from the pilot study [7] and was
performed using STATA® 14 (StataCorp LLC, College
Station, TX, USA). Assuming an alpha of 0.05 and a
power of 0.9, the necessary sample size per group was
413. Accounting for anticipated 10% attrition, the final
sample size needed was 450 per group.
All analyses were performed using SPSS 22.0 (SPSS Inc.,
Chicago, IL, USA). Descriptive statistics were calculated for all
variables. Normality was assessed via Shapiro–Wilk test. Nor-
mally distributed continuous variables were compared using
the t test, with non-normally distributed variables compared
via Mann–Whitney U test. Categorical variables were com-
pared via chi-square and Fisher’s exact test, as appropriate. An
alpha of 0.05 was significant. Multivariate binary logistic re-
gression was performed with backward elimination (Wald)
method. No interim analysis was planned or conducted.
Results
During the 9-month study period, the average hospital ad-
mission and expiration rates were 21,940 and 657 (3%), re-
spectively. The average ICU admission and mortality rates
per institution were 1693 (13,544 total) and 199 (1592 total,
12%), respectively. Of 1454 subjects approached for enroll-
ment, 1396 were randomized, 554 were excluded (58
pre-randomization; 496 post-randomization), and 900 were
included (Fig. 1). Patient demographics were similar between
groups (Table 1), as were admission diagnoses (p= 0.62):
(CFA vs. control) trauma (5% vs. 4%), neurological (20% vs.
17%), renal (24% vs. 24%), cancer (26% vs. 24.7%), respiratory
(21% vs. 23%), and abdominal infection (4% vs. 6%). Time
from ICU admission to cardiopulmonary arrest (10.5 ± 5.7
days vs. 10.3 ± 4.2 days, P= 0.38) and initial recorded rhythm
were similar between groups (Table 2). Total electricity dose
administered for defibrillation was similar between groups
Fig. 2 Proper deployment (a) and rescuer position (b) while using the Cardio First Angel™ device
Table 1 Summary statistics and the results of the tests for comparing groups for demographic variables
Variable Total (n = 900) Intervention (n = 450) Control (n = 450) Significance
Mean ± SD N (%) Mean ± SD N (%) Mean ± SD N (%) P value
Age 57.42 (5.81) 57.26 (5.44) 57.57 (6.16) 0.72a
ICU length of stay (days) 25.82 (10.88) 26.95 (10.82) 24.69 (10.84) < 0.001a
Nurse ICU experience (years) 21.47 (4.70) 21.48 (5.13) 21.46 (4.24) 0.27a
Sex, female 546 (60.7%) 274 (60.9%) 272 (60.4%) 0.89b
Intubated prior to CPR event, Yes 368 (40.9%) 176 (39.1%) 192 (42.7%) 0.28 b
Intubated during CPR event, Yes 34 (7.6%) 36 (8%) 0.83 b
Multi-organ dysfunction, Yes 438 (48.7%) 210 (46.7%) 228 (50.7%) 0.23 b
aMann–Whitney U test
bChi-square test
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(627 J vs. 623 J, P= 0.93), as was first shock success rate
(10.9% vs. 12.7%; P= 0.47; Table 2) and resuscitation drug
and therapy administration (Table 3). Sustained ROSC rates
were improved in the intervention group (66.7% vs. 42.4%, P
< 0.001; Table 2), as was survival to ICU discharge (54% vs.
28.4%, P < 0.001) and survival to hospital discharge (54% vs.
28%, P < 0.001). Intra- and inter-group comparisons for the
first and second half of the study are shown in Table 4. The
CFA group outperformed controls in achieving ROSC and
ICU survival in each subgroup comparison (Table 4). No
intra-group difference was noted for ROSC or ICU survival
in the CFA group over time; however, both improved over
time in the control group. Intra- and inter-group compari-
sons for patients intubated (before or during CPR) versus
those not intubated is shown in Table 5. No difference in
ROSC or survival to discharge was noted within either group
when comparing intubated to non-intubated patients. Simi-
larly, no difference in ROSC or survival to ICU or hospital
Table 2 Summary of resuscitation variables and outcomes
Variable Intervention Control Significance
Mean ± SD Frequency
n = 450 (%)
Mean ± SD Frequency
n = 450 (%)
P value
CPR duration (min) 41.51 (6.67) 42.54 (6.57) 0.025a
Initial cardiac rhythm 0.236b
Asystole 185 (41.1) 183 (40.7)
Ventricular tachycardia 38 (8.4) 33 (7.3)
Ventricular fibrillation 42 (9.3) 61 (13.6)
Pulseless electrical activity and bradyarrhythmia 185 (41.1) 173 (38.4)
First shock success rate 49 (10.9) 57 (12.7) 0.469b
Return of spontaneous circulation 300 (66.7%) 191 (42.4%) < 0.001a
Survival status upon ICU discharge < 0.001b
Alive 269 (59.8) 151 (33.3)
Dead 181 (40.2) 299 (66.4)
Survival status upon hospital discharge < 0.001b
Alive 243 (54) 128 (28.4)
Dead 207 (46) 322 (71.6)
aMann–Whitney U test
bChi-square test
Table 3 Comparison of resuscitation treatments
Treatment administered Treatment dose












































CFA Cardio First Angel™, NS not significant, mg milligrams, g grams, mEq milli-equivalents
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discharge was observed between groups for intubated pa-
tients. A significant difference, however, was noted for ROSC
(66.8% vs. 42.8%, P < 0.0001), survival to ICU discharge
(60.3% vs. 33.3%, P < 0.0001), and survival to hospital dis-
charge (28.3% vs. 54.1%, P < 0.0001) between the interven-
tion and control groups for non-intubated patients.
Five variables correlated with sustained ROSC on
multivariate analysis including the following: no osteo-
porosis, no MOD, age < 65 years, initial rhythm of asys-
tole, or ventricular fibrillation (compared to pulseless
electrical activity; Table 6). Neither sex, CPR duration,
time-of-day (shift), nor admission diagnosis grouping
correlated with sustained ROSC. No patients were
withdrawn for study-associated harms.
Discussion
A large gap exists between current knowledge of CPR
quality and its optimal implementation, contributing to
preventable deaths attributable to cardiac arrest [28]. As
such, quality chest compression remains a focal point of
international guidelines [5, 6], with important components
including compression rate, force, depth, interruptions,
allowing adequate recoil, and avoiding excessive ventila-
tion [2, 3, 29, 30]. One would expect strategies that im-
prove guideline adherence to improve patient outcomes
following IHCA. Real-time AVF is one such strategy iden-
tified by the AHA and ILCOR as an area needing further
investigation [6, 9, 11, 12, 25]. In the 2015 International
Consensus on Cardiopulmonary Resuscitation and Emer-
gency Cardiovascular Care Science with Treatment Rec-
ommendations, feedback device use was recommended to
provide directive feedback on compression rate, depth, re-
lease, and hand position during training (weak recommen-
dation, low-quality evidence). Furthermore, in the absence
of AVF devices, tonal guidance (examples include music
or metronome) during training is recommended to im-
prove compression rate (weak recommendation,
low-quality evidence) [4].
Real-time AVF may be provided by a range of devices,
from basic metronomes to devices using accelerometers,
Table 4 Intra- and inter-group comparisons from the first vs. second halves of the study period
Groups ICU survival Return of spontaneous circulation
Frequency (%) Frequency (%)
Alive Death Yes No
Cardio First Angel™ 1st half 126 (56) 99 (44) 144 (64) 81 (36)
Cardio First Angel™ 2nd half 143 (63.6) 82 (36.4) 156 (69.3) 69 (30.7)
Control 1st half 90 (40) 135 (60) 116 (51.6) 109 (48.4)
Control 2nd half 61 (27.1) 164 (72.9) 75 (33.3) 150 (66.7)
Significance level P < 0.0001a P < 0.0001a
P = 0.103b P = 0.231b
P = 0.001c P = 0.008c
P < 0.0001d P < 0.0001d
P < 0.0001e P < 0.0001e
P < 0.0001f P < 0.0001f
P = 0.004g P < 0.0001g
aChi-square test comparing the variables in all groups
bChi-square test comparing intra-group comparison of Cardio First Angel™ 1st vs. 2nd half
cChi-square test comparing inter-group comparison for 1st half of study
dChi-square test for inter-group comparison for Cardio First Angel™ 1st half to control 2nd half
eChi-square test for inter-group comparison for Cardio First Angel™ 2nd half to control 1st half
fChi-square test comparing inter-group comparison for 2nd half of study
gChi-square test comparing intra-group comparison of controls 1st vs. 2nd half
Table 5 Intra- and inter-group comparison of the effect of intubation status on return of spontaneous circulation and survival to
hospital discharge
Airway status ROSC Inter-
group P
value a
Survival to ICU discharge Inter-
group P
value a















Intubated n (%) 14 (38.9%) 22 (64.7%) 0.31 13 (36.1%) 18 (52.9%) 0.157 11 (30.6%) 18 (52.9%) 0.057
Non-intubated n (%) 177 (42.8%) 278 (66.8%) < 0.0001 138 (33.3%) 251 (60.3%) < 0.0001 117 (28.3) 225 (54.1%) < 0.0001
Intra-group P value 0.53 0.80 0.74 0.4 0.77 0.897
ROSC return of spontaneous circulation
aChi-square test
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springs, or electromagnetic sensing. A recent meta-ana-
lysis reported significant improvements in CPR quality,
but not ROSC, with AED-associated AVF device use,
but no available clinical studies for non-AED devices
[31]. One subsequent clinical trial (n = 80) using the
CFA device reported improved ROSC rates when com-
pared to standard manual compressions [7]. This was
followed by simulation studies using laypersons that
showed improved hand position, mean compression
depth, rate, and compression fraction with the CFA de-
vice [20, 21]. Several other non-AED compression feed-
back devices have shown promising results in simulation
studies but lack clinical testing [7, 15, 16, 18, 22, 32].
This prospective randomized controlled study assessed
the effect of using a non-AED hand-held compression
AVF device on clinical outcomes in patients with IHCA.
The overall rate of ICU mortality (12%) was similar to
that reported in studies of adults in western ICU [33]. It
is known that patient mortality may vary greatly between
institutions and countries [34]. As shown in Table 4, the
overall ROSC rate (55%) in this study was similar to
prior reports from Iran (20%–56%) [7, 35–37], Brazil
(71%) [38], USA (43%–52%) [39, 40], Europe (54%–73%)
[41–44], Turkey (49%) [45], Japan (65%) [46], and
Taiwan (58%–67%) [47, 48] and greater than China
(36%) [49], Hong Kong (38%) [50], and Australia and
New Zealand (46%) [51]. Although the overall discharge
survival rate was higher than previous cohorts, this was
due to improved survival in the experimental group.
When looking only at the control group, the discharge
survival rate was similar to many prior published co-
horts (Table 7) [7, 39–43, 46, 51].
Other factors including sex, age, race, and code status
may have played a role as well. In modern ICUs, circula-
tory failure events are often expected and due to gradual
deterioration. Often, the goals of treatment are modified
resulting in a change in code-status from Full code to a
Limited or No-Code/Do Not Resuscitate status. Such pa-
tients were excluded from this study, resulting in a
patient population at higher risk for cardiac arrest (but
still salvageable).
Moreover, female sex and lower age have been associ-
ated with improved odds of IHCA survival, whereas
black race has been associated with decreased survival
[40, 52, 53]. Although the sex distribution in this study
is consistent with Iran’s national census data, the pro-
portion of females in our study was higher than other
published cohorts [38, 40, 42, 44, 50, 53, 54]. Addition-
ally, the mean age in our cohort was slightly lower than
that in some prior reports (Table 7) [35, 42, 44, 45, 47–
50, 54–56]. Furthermore, the rate of VF/VT may affect
outcomes [53], and although the incidence in published
reports of IHCA has been quite variable, the 18% noted
in our cohort falls mid-spectrum [38, 44–50, 54, 56].
Rates of anti-arrhythmic administration (e.g., Amioda-
rone) were in keeping with other cohorts [54]. In this
study, VF/VT rates were lower than in the pilot study
[7], suggesting that factors other than arrhythmia type
are driving improvements in ROSC and survival rates.
Indeed, a trend toward improved ROSC and survival
rates has been observed in IHCA patients, regardless of
initial rhythm [53].
As it pertains to resuscitation outcomes over time, we
performed both intra- and inter-group comparisons for
the first and second halves of the study. ROSC and sur-
vival to hospital discharge were consistently observed in
the intervention versus control group. This is thought to
reflect CFA device use. Moreover, higher rates of ROSC
and survival to hospital discharge were observed within
the intervention group in the second half of the study
period relative to the first. This may be related to greater
familiarity and comfort with the CFA feedback device.
However, the reasons for improved ROSC and survival
to hospital discharge in the control group for the first
relative to the second half of the study period remain
unclear and necessitate further investigation targeted on
this question as the study was not designed for this
purpose.
Table 6 Variables associated with sustained return of spontaneous circulation as identified through multivariate logistic regression
Step 1a β S.E. Wald df Significance Exp
(β)
95% CI for EXP (β)
Lower Upper
Osteoporosis .325 .136 5.723 1 .017 1.384 1.061 1.807
MOD −.275 .136 4.101 1 .043 .759 .582 .991
Age < 65 years .327 .142 5.311 1 .021 1.387 1.050 1.832
Rhythm 7.979 3 .046
Asystole .723 .321 5.064 1 .024 2.060 1.098 3.865
VT .202 .225 .805 1 .370 1.224 .787 1.904
VF .457 .227 4.062 1 .044 1.579 1.013 2.463
PEA and bradyarrhythmia −.371 .238 2.441 1 .118 .690
MOD multiple organ dysfunction, VT ventricular tachycardia, VF ventricular fibrillation, PEA pulseless electrical activity
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It remains unknown whether endotracheal intubation
offers ROSC or survival benefits over bag-valve-mask
ventilation or supraglottic airway placement during re-
suscitation for IHCA. Small non-randomized studies
have suggested a benefit [45, 48, 56, 57], whereas others
have suggested the absence of need for endotracheal in-
tubation as being associated with improved survival [58].
However, data from a large administrative database


















Total 900 100 100 57 61 18 55 42
CFA 450 100 100 57 61 18 67 54
Control 450 100 100 58 60 21 42 28
ANZ b [51] 1733 80 NR NR 36 31 46 25
Austria [44] 1041 NR 96 64 37 39 NR 36c
Brazil [38] 89 100 100 59 48 15 71 9
China [49] 2712 NR 7 62 32 57 36 9
Hong Kong [50] 431 60 17 71-74d 38 6 38 5
India [56] 105 100 100 51 25 5 38 1
Iran [7]
Total
80 100 100 61 61 58 54 NR
CFA
40 100 100 60 55 58 73
Control
40 100 100 63 66 58 35
Iran [36] 80 100 NR 67 52 NR 56
Iran [37] 600 NR 26 NR 42 NR 45 3
Iran [35] 206 NR 31 54 41 NR 20 5
Ireland [41] 741 75 42 66 32 NR 56 18
Ireland [42] 63 87 11 74 37 NR 73 27
Japan [46] 491 77 25 71 38 28 65 28e
Norway [43] 302 85 1 70 36 NR 54 25
Taiwan [47] 110 NR NR 67 29 14 67 18
Taiwan [48] 702 50 21 67 39 88 58 6
Turkey [45] 134 NR 32 67 51 18 49 13
UAE [66] 685 NR 46 57 34 9 38 8
USA [54] 14,720 86 51 68 43 25 44 17
USA [39] 16,245 88 NR NR NR NR 52 23
USA [59] 25,006 72 37 NR 42 17 50 15
USA [53] 84,625 100 100 66 42 21 43 17
USA [60] 471,962 NR NR NR 48 NR NR 18
USA [40] 235,959 NR NR 51 42 NR NR 30
IHCA in-hospital cardiac arrest, ICU intensive care unit, CCU cardiac care unit, OR operating room, VF ventricular fibrillation, VT ventricular tachycardia, CFA Cardio
First Angel™, NR not reported, ANZ Australia and New Zealand, UAE United Arab Emirates, USA United States of America
aNumbers rounded to nearest whole number
bMeta-analysis of studies from Australia and New Zealand
cDuration of survival not specified. Additionally, survival only reported for those with good neurological outcome defined as Glasgow–Pittsburgh cerebral
performance categories (CPC) 1 and 2. CPC 1 indicates good capability, CPC 2 indicates slight disability, CPC 3 indicates severe disability, CPC 4 indicates coma or
vegetative state, CPC 5 indicates cerebral death. CPC score of 1 or 2 was considered favorable, while a score of 3, 4, or 5 indicated an unfavorable functional
neurological outcome
dOnly range reported
e30-day survival. Survival to hospital discharge not reported
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study (25,006 cardiopulmonary arrest events) found that
early invasive airway insertion was not associated with
improved ROSC rates, and only slightly better odds of
24 h survival (adjusted OR 0.94, 0.89–0.99) [59]. More-
over, data from both non-randomized clinical studies
[47] and large administrative database [60] studies have
reported that patients who were already intubated or
had received mechanical ventilation before resuscitation
had reduced ROSC and survival. We performed both
intra- and inter-group comparisons to further assess the
impact of intubation on resuscitation outcome. We
found no difference in ROSC, or survival to ICU dis-
charge, or survival to hospital discharge for intra-group
comparisons based on intubation status. Furthermore,
differences in these outcomes were noted only for
inter-group comparisons of non-intubated patients, but
not intubated ones. The etiology for this is thought to be
due to improved CPR quality in the intervention group,
but further investigation focused on this finding are
needed to better clarify the matter.
Work environment may also play a role in IHCA sur-
vival [61–64]. It has been estimated that an increase by
one full-time registered nurse per patient ICU day re-
duces IHCA relative risk by 28% [65]. Shift time (day,
eve, night) does not seem to be a significant factor in
IHCA survival in this and other studies [53]. Lastly, the
use of therapeutic hypothermia after IHCA varies across
studies, and in Iran, it is not common.
Limitations
This study did not enroll patients with primary cardiac
conditions; such patients were admitted to the cardiac
ICU. This study was not designed to follow neurologic
outcomes, as such, data regarding functional outcome is
not available. Unfortunately, the study was not designed
to capture data on compression rate, depth, chest recoil,
no flow time, or flow fraction. In future studies we will
plan to incorporate some (or all) of these variables.
Moreover, invasive arterial monitoring and wave form
capnography were not routinely available at the time of
the study and is not reported.
A significant limitation of compression feedback de-
vice studies is the inability to blind the clinical providers.
Blinding the subject, the investigator, and the data ana-
lysts is easy and was done in this case. But to blind the
clinical provider, one would need to either (1) use a
sham device or (2) not allow the clinician to “see” the
patient being resuscitated during device application and
“hide” the device during compression pauses. Sham de-
vice use was deemed to be unethical, and the latter im-
practical. Furthermore, one criticism of the current
non-AED compression feedback devices is that they do
not account for complex changes that occur during
CPR. Like other AVF devices, CFA accounts for neither
complex changes in chest wall compliance and elasticity,
nor the compressibility of the surface the patient is lying
on (e.g., mattress). Lastly, future investigations would
benefit from optimization of the methodology to detect
morbidity including sternum and rib fractures.
Additionally, assessments for chest wall morbidity (rib
or sternum fractures) were not uniform (X-ray, CT scan,
autopsy) precluding extrapolation of conclusions. This
was in part due to funding and resource limitations. Fu-
ture investigations should improve upon these limitations.
Conclusion
This is the first large-scale clinical trial comparing chest
compressions using a hand-held non-AED compression
AVF device to standard manual chest compressions dur-
ing IHCA. Use of the CFA device improved sustained
ROSC, ICU survival, and survival to hospital discharge.
This study is the first of its kind to show that use of an
inexpensive compression AVF device may improve pa-
tient outcomes from IHCA. This may have tangible ef-
fects for both wealthy and resource-limited institutions.
Further prospective clinical investigation comparing
CFA to other commercially available AVF devices is
needed to clarify the performance characteristics and po-
tential benefit of using these devices.
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